Albrecht Kretzschmar
- Gastroenterology top 1%
- Gastrointestinal Tumor Research and Treatment 11
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 34
- Cancer Treatment and Pharmacology 18
- Cancer Diagnosis and Treatment 7
-
- Gastric Cancer Management and Outcomes 37
- Metastasis and carcinoma case studies 8
- Lung Cancer Treatments and Mutations 7
- Hepatology top 2%
- Internal Medicine top 5%
-
- Esophageal Cancer Research and Treatment 7
- Co-authors
- Peter ReichardtPeter Thuss‐PatienceAxel HinkeDmitry BichevGuido SchumacherDaniel PinkBernhard GebauerBernd Dörken
- Journals
- Journal of Clinical Oncology (30 papers)European Journal of Cancer (6 papers)Annals of Oncology (5 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Albrecht Kretzschmar
68 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 80
- Gastroenterology 388
- Oncology 1.6k
- Pulmonary and Respiratory Medicine 1.5k
- Hepatology 325
- Internal Medicine 143
Countries citing papers authored by Albrecht Kretzschmar
This map shows the geographic impact of Albrecht Kretzschmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albrecht Kretzschmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albrecht Kretzschmar more than expected).
Fields of papers citing papers by Albrecht Kretzschmar
This network shows the impact of papers produced by Albrecht Kretzschmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albrecht Kretzschmar. The network helps show where Albrecht Kretzschmar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Albrecht Kretzschmar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2020 | 3 | |
| 4 | 2020 | 24 | |
| 5 | 2017 | 2 | |
| 6 | 2012 | 56 | |
| 7 | Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer – A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)breakdown → | 2011 | 429 |
| 8 | 2011 | 21 | |
| 9 | 2009 | 14 | |
| 10 | 2009 | 423 | |
| 11 | 2008 | 55 | |
| 12 | 2008 | 27 | |
| 13 | 2007 | 14 | |
| 14 | 2006 | 2 | |
| 15 | 2005 | 159 | |
| 16 | 2005 | 29 | |
| 17 | 2003 | 12 | |
| 18 | 2000 | 17 | |
| 19 | 1997 | 2 | |
| 20 | Arbeiterklasse und Persönlichkeit im Sozialismus | 1977 | 1 |
About Albrecht Kretzschmar
Albrecht Kretzschmar is a scholar working on Gastroenterology, Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Internal Medicine, having authored 71 papers that have together received 2.5k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (37 papers), Colorectal Cancer Treatments and Studies (34 papers), Cancer Treatment and Pharmacology (18 papers), Gastrointestinal Tumor Research and Treatment (11 papers), Metastasis and carcinoma case studies (8 papers), Cancer Diagnosis and Treatment (7 papers), Esophageal Cancer Research and Treatment (7 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Gastroenterology (388 citations), Oncology (1.6k citations), Pulmonary and Respiratory Medicine (1.5k citations), Hepatology (325 citations) and Internal Medicine (143 citations). Albrecht Kretzschmar has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Peter Reichardt, Peter Thuss‐Patience, Axel Hinke, Dmitry Bichev, Guido Schumacher, Daniel Pink, Bernhard Gebauer, Bernd Dörken, Kirstin Breithaupt and David Cunningham. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology, British Journal of Cancer and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.